Can enzyme kinetics of prooxidants teach us a lesson about the treatment of Alzheimer's disease: A pilot post-mortem study

References

• Ancelin M-L, Christen Y, Ritchie K. 2007. Is antioxidant therapy a viable alternative for mild cognitive impairment? Examination of the evidence. Dement Geriatr Cogn Disord 24:1–19.
   PubMed Web of Science ®Google Scholar
• Atamna H, Nguyen A, Schultz C, Boyle K, Newberry J, Kato H, . 2008. Methylene blue delays cellular senescence and enhances key mitochondrial biochemical pathways. FASEB J 22:703–712.
   PubMed Web of Science ®Google Scholar
• Bradford AJ, McDonnell JM, Marini JC, Korngold RA. 1976. Rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368:744–746.
   Google Scholar
• Brunstein MG, Ghisolfi ES, Ramos FL, Lara DR. 2005. A clinical trial of adjuvant allopurinol therapy for moderately refractory schizophrenia. J Clin Psychiatry 66:213–219.
   PubMed Web of Science ®Google Scholar
• Del Villar K, Miller CA. 1984. Down-regulation of DENN/MADD, a TNF receptor binding protein, correlates with neuronal cell death in Alzheimer's disease brain and hippocampal neurons. Proc Natl Acad Sci USA 23:4210–4215.
   Google Scholar
• Desikan RS, Fischl B, Cabral HJ, Kemper TL, Guttmann CR, Blacker D, . 2008. MRI measures of temporo-parietal regions show differential rates of atrophy during prodromal AD. Neurology 71:819–825.
   PubMed Web of Science ®Google Scholar
• Durany N, Muench G, Michel T, Riederer P. 1999. Investigations on oxidative tress and therapeutic implications in dementia. Eur Arch Psychiatry Clin Neurosci (Germany) 249:68–73.
   PubMed Web of Science ®Google Scholar
• Eichenbaum H, Otto T, Cohen NJ. 1992. The hippocampus – what does it do? Behav Neural Biol 57:236.
   Google Scholar
• Furuta A, Price DL, Pardo CA, Troncoso JC, Xu ZS, Taniquchi N, . 1995. Localization of superoxide dismutases in Alzheimer's disease and Downs syndrome neocortex and hippocampus. Am J Pathol 146:357–367.
   PubMed Web of Science ®Google Scholar
• Goldsbury C, Whiteman IT, Jeong E, Lim YA. 2008. Oxidative stress increases levels of endogenous amyloid-beta peptides secreted from primary chick brain neurons. Aging Cell 7:771–5.
   PubMed Web of Science ®Google Scholar
• Guercionni R, Szumlanski C, Weinshilboum RM. 1991. Human liver xanthine oxidase: nature and extent of individual variation. Clin Pharmacol Ther 50:663–672.
   PubMed Web of Science ®Google Scholar
• Grünblatt E, Mandel S, Jacob-Hirsch J, Zeligson S, Amariglo N, Rechavi G, . 2004. Gene expression profiling of parkinsonian substantia nigra pars compacta; alterations in ubiquitin-proteasome, heat shock protein, iron and oxidative stress regulated proteins, cell adhesion/cellular matrix and vesicle trafficking genes. J Neural Transm 111:1543–1573.
   PubMed Web of Science ®Google Scholar
• Gsell W, Lange KW, Pfeuffer R, Heckers S, Heinsen H, Senitz D, . 1993. How to run a brain bank. A report from the Austro-German brain bank. J Neural Transm Suppl 39:31–70.
   PubMedGoogle Scholar
• Halliwell B, Gutteridge JMC. 1984. Oxygen toxicity, oxygen radicals, transition metals and disease. Biochem J 219:1–14.
   PubMed Web of Science ®Google Scholar
• Harrison R. 2002. Structure and function of xanthine oxido-reductase: where are we now? Free Radic Biol Med 33:774–797.
   PubMed Web of Science ®Google Scholar
• Harmann A. 1992. Role of free radicals in aging and disease. Ann NY Acad Sci 673:126–141.
   PubMed Web of Science ®Google Scholar
• Jellinger K. 1998. The neuropathological diagnosiss of Alzheimer's disease. J Neural Transm 53:97–118.
   Google Scholar
• Khatchaturian ZS. 1985. Diagnosis of Alzheimer's disease. Arch Neurol 42:1097–1105.
   PubMedGoogle Scholar
• Maier CM, Chan PK. 2002. Role of superoxide dismutases in oxidative damage in neurodegenerative disorders. Neuroscientist 8:323–334.
   PubMed Web of Science ®Google Scholar
• McKhann G, Drachman D, Folstein M, Kathman R, Price D, Stadlan EM. 1984. Clinical diagnosis of Alzheimer's disease: report of the NINCDS_ADRDA Work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 34:939–944.
   PubMed Web of Science ®Google Scholar
• Michel TM, Thome J, Nara K, Martin D, Camara S, Weijers HG, . 2004. The role of oxidative stress in the pathogenesis of schizophrenic psychoses – superoxide dismutase (SOD)-coenzyme con-centrations in post-mortem brain tissue of schizophrenic patients. J Neural Transm 111:1191–1201.
   PubMed Web of Science ®Google Scholar
• Michel TM, Frangou S, Thiemeyer D, Camara S, Zoechling R, Jecel J, . 2007. Evidence for oxidative stress in the frontal cortex in patients with recurrent depressive disorder – a post-mortem study. Psychiatry Res 15:145–150.
   Google Scholar
• Michel TM, Frangou S, Camara S, Tatschner T, Sheldrick AJ, Riederer P, . 2008a. Evidence for increased oxidative stress in the thalamus and in the putamen in patients with recurrent depressive disorder – a post-mortem investigation. World J Biol Psychiatry 13:1–11.
   Google Scholar
• Michel TM, Frangou S, Camara S, Thiemeyer D, Jecel J, Tatschner T. 2008b. Altered glial cell line-derived neurotrophic factor (GDNF) concentrations in the brain of patients with depressive disorder. A comparative post-mortem study. Eur Psychiatry 23:413–420.
   PubMed Web of Science ®Google Scholar
• Michel TM, Gsell W, Käsbauer L, Tatschner T, Sheldrick AJ, Neuner I, . 2010. Increased activity of mitochondrial aldehyde dehydrogenase (ALDH) activity in the putamen of individuals with Alzheimer's disease – a preliminary human post-mortem study. J Alzheimer's Dis 19:1295–1301.
   PubMed Web of Science ®Google Scholar
• Mirra S. 1997. Neuropathological assessment of Alzheimer's disease: the experience of the consortium to establish a registry for Alzheimer's disease. Int Psychogeriatr 9:263–268.
   PubMedGoogle Scholar
• Parks DA, Granger DN. 1986. Xanthine oxidase: biochemistry, distribution, and physiology. Acta Physiol Scand 548:87–99.
   Google Scholar
• Poulin P, Zakzanis KK. 2006. In vivo neuroanatomy of Alzheimer's disease: evidence from structural and functional brain imaging. Brain Cogn 49:220–225.
   Google Scholar
• Sheng JG, Zhou XQ, Mrak RE, Griffin WS. 2005. Progressive neuronal injury asso plaque formation cause structural injury to neuronal processes? Neurotox Res 7:5–15.
   PubMed Web of Science ®Google Scholar
• Squire LR. 1999. Memory and the hippocampus: a synthesis from findings with rats, monkeys, and humans. Psychol Rev 99:195–231.
   Google Scholar
• Tierney MC, Fisher RH, Lewis AJ, Zorzitto ML, Snow WG, Reid DW, . 1988. The NINCDS-ADP, DA workgroup criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology 38:359–364.
   PubMed Web of Science ®Google Scholar
• Veurink G, Fuller SJ, Atwood CS, Martins RN. 2003. Genetics, lifestyle and the roles of amyloid beta and oxidative stress in Alzheimer's disease. Ann Human Biol 30:639–67.
   PubMed Web of Science ®Google Scholar
• WHO 1992. ICD10, World Health Organization. International Statistical Classification of Diseases and Related Health Problems. 4th revision 2000.
   Google Scholar